A Treatment Within Sight: Challenges in the development of stem cell-derived photoreceptor therapies for retinal degenerative diseases

Davinia Beaver, Jason Ionnis Limnios*

*Corresponding author for this work

Research output: Contribution to journalReview articleResearchpeer-review

66 Downloads (Pure)

Abstract

Stem cell therapies can potentially treat various retinal degenerative diseases, including age-related macular degeneration (AMD) and inherited retinal diseases like retinitis pigmentosa. For these diseases, transplanted cells may include stem cell-derived retinal pigmented epithelial (RPE) cells, photoreceptors, or a combination of both. Although stem cell-derived RPE cells have progressed to
human clinical trials, therapies using photoreceptors and other retinal cell types are still under development. In this review, we discuss the potential use of human pluripotent stem cell (hPSC)-derived photoreceptors for the treatment of retinal degeneration and highlight the progress and challenges for their efficient production and clinical application in regenerative medicine.
Original languageEnglish
Pages (from-to)1-16
Number of pages16
JournalFrontiers in Transplantation
DOIs
Publication statusPublished - 29 Sept 2023

Fingerprint

Dive into the research topics of 'A Treatment Within Sight: Challenges in the development of stem cell-derived photoreceptor therapies for retinal degenerative diseases'. Together they form a unique fingerprint.

Cite this